ENST00000636768.2:n.*2084A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000636768.2(CACNA1A):​n.*2084A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00746 in 154,954 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 4 hom., cov: 26)
Exomes 𝑓: 0.0078 ( 0 hom. )

Consequence

CACNA1A
ENST00000636768.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.38

Publications

2 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 19-13207011-T-C is Benign according to our data. Variant chr19-13207011-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1211720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00742 (1024/138080) while in subpopulation NFE AF = 0.0102 (662/65060). AF 95% confidence interval is 0.00953. There are 4 homozygotes in GnomAd4. There are 497 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High AC in GnomAd4 at 1024 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.*302A>G 3_prime_UTR_variant Exon 47 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000636768.2 linkn.*2084A>G non_coding_transcript_exon_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*3002A>G non_coding_transcript_exon_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000360228.11 linkc.*302A>G 3_prime_UTR_variant Exon 47 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000637769.1 linkc.*302A>G 3_prime_UTR_variant Exon 47 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000637736.1 linkc.*302A>G 3_prime_UTR_variant Exon 46 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636389.1 linkc.*909A>G 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000635895.1 linkc.*1035A>G 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.*1035A>G 3_prime_UTR_variant Exon 47 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000636768.2 linkn.*2084A>G 3_prime_UTR_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*3002A>G 3_prime_UTR_variant Exon 47 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.00742
AC:
1024
AN:
137992
Hom.:
4
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00115
Gnomad AMR
AF:
0.00677
Gnomad ASJ
AF:
0.00624
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00177
Gnomad FIN
AF:
0.0228
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0102
Gnomad OTH
AF:
0.00677
GnomAD4 exome
AF:
0.00782
AC:
132
AN:
16874
Hom.:
0
Cov.:
0
AF XY:
0.00850
AC XY:
76
AN XY:
8944
show subpopulations
African (AFR)
AF:
0.00226
AC:
1
AN:
442
American (AMR)
AF:
0.00813
AC:
4
AN:
492
Ashkenazi Jewish (ASJ)
AF:
0.00469
AC:
3
AN:
640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1770
South Asian (SAS)
AF:
0.00163
AC:
1
AN:
614
European-Finnish (FIN)
AF:
0.0165
AC:
23
AN:
1396
Middle Eastern (MID)
AF:
0.0217
AC:
2
AN:
92
European-Non Finnish (NFE)
AF:
0.00844
AC:
87
AN:
10314
Other (OTH)
AF:
0.00987
AC:
11
AN:
1114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00742
AC:
1024
AN:
138080
Hom.:
4
Cov.:
26
AF XY:
0.00750
AC XY:
497
AN XY:
66266
show subpopulations
African (AFR)
AF:
0.00133
AC:
49
AN:
36852
American (AMR)
AF:
0.00676
AC:
90
AN:
13320
Ashkenazi Jewish (ASJ)
AF:
0.00624
AC:
21
AN:
3366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4490
South Asian (SAS)
AF:
0.00177
AC:
7
AN:
3962
European-Finnish (FIN)
AF:
0.0228
AC:
181
AN:
7956
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.0102
AC:
662
AN:
65060
Other (OTH)
AF:
0.00672
AC:
13
AN:
1934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.530
Heterozygous variant carriers
0
47
94
141
188
235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00731
Hom.:
0
Bravo
AF:
0.00628
Asia WGS
AF:
0.00202
AC:
8
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
11
DANN
Benign
0.88
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111240372; hg19: chr19-13317825; API